Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Overweight × Cyproterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Overweight 1 Obesity 1

Interventions

Metformin 2 sultamicillin 1 Ursodeoxycholic Acid 1 Tirzepatide 1 Propofol 1 Exercise 1 Exenatide 1 Docosahexaenoic Acids 1 Cyproterone 1 (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03151005 2023-12-04

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Xinqiao Hospital of Chongqing

Phase 4 Completed

70 enrolled 11 charts

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡